Early Clinical Results Of A Novel Anti-Cd20 Chimeric Antigen Receptor (Car)-T Cell Therapy For B-Cell Nhl Patients Who Are Relapsed/Resistant Following Cd19 Car-T Therapy
BLOOD(2020)
摘要
Background:
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要